Caspase-1: An Inflammatory Cysteine Protease
============================================

Caspases are evolutionary conserved cysteine proteases that cleave their substrates behind aspartate residues (Lamkanfi et al., [@B31]). Caspase-mediated substrate proteolysis results in activation or inactivation of critical signaling cascades regulating programmed cell death, differentiation, and cell proliferation (Lamkanfi et al., [@B32]). Dysregulated activity of the founding father of mammalian caspases, interleukin (IL)-1β-converting enzyme and later renamed caspase-1, has been linked to inflammatory bowel diseases (Villani et al., [@B71]; Allen et al., [@B3]; Dupaul-Chicoine et al., [@B13]; Zaki et al., [@B73],[@B74]), gouty arthritis (Martinon et al., [@B47]), type II diabetes (Larsen et al., [@B40]), and less common autoinflammatory disorders that are collectively referred to as cryopyrinopathies (Lamkanfi and Kanneganti, [@B37]).

Caspase-1 modulates inflammatory and host defense responses against microbial pathogens by processing the precursor forms of the pro-inflammatory cytokines IL-1β and IL-18 into their biologically active forms (Kuida et al., [@B28]; Li et al., [@B42]; Ghayur et al., [@B18]; Gu et al., [@B19]). Caspase-1-mediated maturation of IL-1β and IL-18 is critical for their secretion from activated monocytes and macrophages. These related cytokines mediate critical aspects of the local and systemic immune response to infection including the induction of fever, transmigration of leukocytes into sites of injury or infection, and activation and polarization of T helper 1 (T~H~1) and T~H~2 responses (Dinarello, [@B9]). In addition to secreting IL-1β and IL-18, caspase-1 also mediates the release of the damage-associated molecular pattern (DAMP) high mobility group box 1 (HMGB1) from macrophages infected with the facultative intracellular pathogen *Salmonella typhimurium* (Lamkanfi et al., [@B39]). Moreover, caspase-1 was shown to activate the executioner caspase-7 (Lamkanfi et al., [@B38]; Akhter et al., [@B2]), to inactivate glycolysis enzymes (Shao et al., [@B60]), and to induce a specialized form of cell death known as "pyroptosis" in macrophages infected with the bacterial pathogens *Shigella flexneri*, *S. typhimurium*, *Pseudomonas aeruginosa*, *Legionella pneumophila, Bacillus anthracis, Staphylococcus aureus, Listeria monocytogenes*, and *Francisella tularensis* (Lamkanfi and Dixit, [@B36]). In addition to preventing pathogen replication in infected immune cells, pyroptosis may enhance host defense responses by presenting intracellular microbial antigens to cells of the immune system (Lamkanfi and Dixit, [@B36]; Miao et al., [@B53]).

Caspase-1 Activation by Inflammasomes
=====================================

Caspase-1 is produced as an inactive zymogen that is recruited and activated by cytosolic multi-protein complexes known as inflammasomes (Lamkanfi and Dixit, [@B35]). These protein complexes are assembled in cells of myeloid and epithelial origin upon recognition of DAMPs and pathogen-associated molecular patterns in intracellular compartments, similar to the role of mammalian Toll-like receptors at the cell surface and within endosomes (Kawai and Akira, [@B24]). Inflammasomes contain members of the NOD-like receptor (NLR) or the HIN-200 receptor family, namely the NLRs Nlp1b, Nlrp3, and Nlrc4, or the HIN-200 protein absent in melanoma (AIM2; Figure [1](#F1){ref-type="fig"}). These receptors are recruited into the inflammasome in a pathogen-specific manner (Lamkanfi and Dixit, [@B35]). Nlrp3 is required for caspase-1 activation in response to microbial products with diverse molecular structures such as LPS, peptidoglycan, and lipoteichoic acid, upon exposure to microbial toxins and ionophores such as nigericin, endogenous alarmins such as ATP, and in response to infection with bacterial and fungal pathogens such as *S. aureus*, *Streptococcus pneumoniae*, and *Candida albicans*, respectively (Kanneganti et al., [@B22],[@B23]; Mariathasan et al., [@B46]; Sutterwala et al., [@B67]; McNeela et al., [@B49]). In addition, the DAMPs monosodium urate and calcium pyrophosphate dehydrate crystals also activate the Nlrp3 inflammasome, suggesting a role for this inflammasome in the etiology of gouty arthritis and pseudogout (Martinon et al., [@B47]). By contrast, the Nlrc4 inflammasome is activated in macrophages infected with intracellular pathogens such as *S. typhimurium*, *L. pneumophila, P. aeruginosa, and S. flexneri* as illustrated by the observation that caspase-1 activation is largely abolished in *Ipaf* deficient macrophages infected with these intracellular pathogens (Mariathasan et al., [@B45]; Amer et al., [@B4]; Franchi et al., [@B15], [@B16]; Miao et al., [@B51], [@B52]; Lamkanfi et al., [@B29]; Sutterwala et al., [@B66]; Suzuki et al., [@B68]). In contrast, *B. anthracis* Lethal Toxin (LT) triggers activation of the Nlrp1b inflammasome in mouse macrophages and mutations in the *Nlrp1b* gene were identified as the key susceptibility locus for Anthrax LT-induced macrophage death (Boyden and Dietrich, [@B7]). Finally, additional inflammasome complexes such as the recently identified AIM2 inflammasome, are responsible for activation of caspase-1 in macrophages infected with *F. tularensis*, *L. monocytogenes* and in response to DNA viruses such as cytomegalovirus and vaccinia virus (Fernandes-Alnemri et al., [@B14]; Jones et al., [@B21]; Rathinam et al., [@B55]; Sauer et al., [@B58]).

![**Modulation of inflammasomes by microbial pathogens**. *Bacillus anthracis* activates the Nlrp1b inflammasome, whereas *Staphylococcus aureus, Streptococcus pneumonia*, and *Candida albicans* induce caspase-1 activation via Nlrp3. *Salmonella typhimurium*, *Shigella flexneri*, *Legionella pneumophila*, and *Pseudomonas aeruginosa* all make use of a bacterial type III or IV secretion system to inject effector proteins that are recognized by the Nlrc4 inflammasome. Finally, *Francisella tularensis* induces activation of the AIM2 inflammasome when genomic DNA of replicating bacteria is detected in the cytosol of infected macrophages. Orthopoxviruses interfere with inflammasome function at several steps. They produce pyrin-only decoy proteins (vPOPs) that bind the inflammasome adaptor ASC to prevent caspase-1 recruitment and inhibit caspase-1 activity directly with virally encoded serpins such as the cowpox serpin CrmA and its homologs encoded by myxoma and vaccinia virus. Finally, orthopoxviruses evolved scavenger receptors for secreted IL-1β (vIL-1βR) and IL-18 (vIL-18BP) to prevent activation of downstream signaling cascades. Influenza virus NS1 protein dampens caspase-1 activation and secretion of IL-1β and IL-18 through a yet unknown mechanism that requires its amino-terminal RNA-binding domain. The *Yersinia* virulence factors YopE and YopT and the *Pseudomonas* effector ExoS inhibit caspase-1 activation, possibly through an indirect mechanism involving inhibition of Rho GTPase-mediated cytoskeletal changes. On the other hand, the phospholipase A2 activity of *Pseudomonas* ExoU is required for inhibiting caspase-1 activation, while *Yersinia* YopK prevents recognition of the bacterial type III secretion system.](fmicb-02-00003-g001){#F1}

Caspase-1 Inhibition by Orthopoxvirus-Encoded Serpins
=====================================================

Given the central role inflammasomes play in modulating replication and dissemination of microbial pathogens, certain viruses and bacteria have evolved mechanisms to counter the induction of caspase-1 activation and activity. One mechanism by which microbial pathogens interfere with inflammasome functions is by directly targeting the enzymatic activity of caspase-1. The cowpox virus protein Cytokine response modifier A (CrmA) and its homologs in orthopoxviruses such as vaccinia, ectromelia, and rabbitpox virus probably represent the best characterized examples of this class of inflammasome inhibitors (Dobbelstein and Shenk, [@B10]; Macen et al., [@B43]; Turner et al., [@B70]; Best, [@B6]). Although classified as serine protease inhibitors (serpins), these virus-encoded proteins function as pseudosubstrate inhibitors of caspase-1 (Ray et al., [@B56]; Komiyama et al., [@B27]; Best, [@B6]). They form covalent bonds with the active site cysteine after being processed by caspase-1, thus blocking its enzymatic activity. Indeed, CrmA inhibits caspase-1 activity with a *K*~I~ of 0.01 nM, rendering it one of the most effective inhibitors known for this protease. Notably, CrmA shares 54% amino acid identity with the human serpin PI-9 (Sprecher et al., [@B62]) and has two homologs in rodents (Sun et al., [@B65]). Although the reactive loop aspartate residue where caspase-mediated processing occurs in CrmA is mutated to glutamate in PI-9 (Annand et al., [@B5]), the latter serpin is capable of inhibiting caspases as illustrated by the observation that it prevents caspase-1-mediated processing of IL-1β and IL-18 in vascular smooth muscle cells (Young et al., [@B72]). Importantly, in addition to blocking caspase-1 activation, CrmA and its homologs inhibit the protease activity of the apoptotic initiators caspases-8 and -10 as well (Dobbelstein and Shenk, [@B10]; Macen et al., [@B43]; Turner et al., [@B70]; Best, [@B6]). Thus, poxviruses have devised a way to simultaneously interfere with inflammatory and apoptotic signaling cascades. Serpin-mediated caspase-1 inhibition prevents secretion of IL-1β and IL-18 and delays the induction of effective host defense responses. Moreover, by preventing programmed cell death of infected host cells, poxviruses can replicate in intracellular niches and spread to adjacent cells before being recognized by cells of the host\'s immune system.

The critical role of CrmA and other serpins in poxvirus virulence is demonstrated by the observation that CrmA deficiency reduced the lesion size and numbers on the chorio-allantoic membrane of developing chick embryos (Ray et al., [@B56]; Palumbo et al., [@B54]). Moreover, deletion of CrmA attenuated virulence in intranasally and intracranially infected Balb/c and C57BL/6 mice (Thompson et al., [@B69]; Palumbo et al., [@B54]; MacNeill et al., [@B44]). Similarly, deletion of the CrmA homolog Serp2 in myxoma virus causes a dramatic reduction in viral titers in infected rabbits (Messud-Petit et al., [@B50]). By contrast, vaccinia virus mutants lacking the CrmA homologs SPI-1 and SPI-2 did not display changes in virulence in intranasally infected Balb/c mice (Kettle et al., [@B26]). This may be explained by the observation that vaccinia virus encodes a scavenger receptor called virus-encoded IL-1β receptor (vIL-1βR) that neutralizes secreted IL-1β (Kettle et al., [@B25]). In addition, vaccinia, ectromelia, and cowpox viruses encode soluble IL-18-binding proteins (vIL-18BPs) that prevent activation of inflammatory pathways downstream of the IL-18 receptor (Smith et al., [@B61]). Thus, orthopoxviruses make use of serpins to inhibit caspase-1 activity and modulate signaling downstream of caspase-1 through scavenger receptors to increase virulence.

Inhibition of Inflammasome Assembly by Orthopoxvirus Decoy Proteins
===================================================================

In addition to modulating inflammasome signaling at the level of caspase-1 and its substrates, orthopoxviruses devised mechanisms to prevent activation of this inflammatory protease altogether. Indeed, Myxoma virus and Shope Fibroma virus encode pyrin-only decoy molecules that interfere with inflammasome assembly to inhibit caspase-1 activation (Johnston et al., [@B20]; Dorfleutner et al., [@B11]). In this regard, the myxoma virus M013L and Shope Fibroma virus S013L pyrin-only proteins (POPs) resemble the POPs and caspase recruitment domain (CARD)-only proteins encoded in the human genome (Lamkanfi et al., [@B30]; Stehlik and Dorfleutner, [@B64]). The human CARD-only proteins COP, INCA, ICEBERG, and CASP12~S~ all bind the caspase-1 CARD to prevent activation of caspase-1 and the subsequent generation of IL-1β (Druilhe et al., [@B12]; Lee et al., [@B41]; Lamkanfi et al., [@B33],[@B34]; Saleh et al., [@B57]). In contrast, human cPOP1 and cPOP2, and viral POPs interact with the pyrin domain of the inflammasome adaptor protein ASC and pyrin motifs found in certain NLRs to prevent recruitment and activation of caspase-1 by inflammasomes (Stehlik and Dorfleutner, [@B64]). The relevance of vPOPs during infection is provided by the observation that deletion of the gene encoding myxoma virus M013L results in decreased viremia as a result of increased inflammatory responses and attenuated viral replication during myxomatosis (Johnston et al., [@B20]). Thus, the diverse mechanisms orthopoxviruses evolved to prevent and interfere with caspase-1 signaling suggest that inflammasomes play a critical role in the host response against these pathogens.

Inhibition of Inflammasome Signaling by Influenza Virus
=======================================================

Viral modulation of inflammasome signaling is not limited to the orthopoxviruses described above. Interestingly, Influenza virus uses an unrelated mechanism to prevent caspase-1 activation and interfere with inflammasome signaling. Human influenza A/PR/8/34 (H1N1) virus was shown to inhibit production of IL-1β and IL-18 through inhibition of caspase-1 maturation in infected macrophages (Stasakova et al., [@B63]). Mutant viruses lacking the influenza NS1 gene were incapable of preventing caspase-1 activation and triggered secretion of significantly increased levels of IL-1β and IL-18 from infected host cells. These mutant viruses were attenuated *in vitro*, but it is unclear whether caspase-1 activation is solely responsible for this phenotype. Regardless, structure--function studies demonstrated that the amino-terminal RNA-binding/dimerization domain of NS1 is essential for inhibition of caspase-1 activation and the secretion of mature IL-1β and IL-18, whereas the carboxy-terminal effector domain was not required (Stasakova et al., [@B63]). Although the molecular mechanism by which influenza NS1 inhibits caspase-1 activation has not been uncovered, NS1 may interfere with a critical step involved in inflammasome assembly. Further study in this direction may unveil interesting new mechanisms by which viruses target inflammasomes.

Negative Regulation of Inflammasome Activation by Bacterial Virulence Factors
=============================================================================

In addition to the viruses described above, several Gram-positive and --Gram-negative bacterial pathogens have been demonstrated to interfere with inflammasome activation. Enteropathogenic *Yersinia enterocolitica* bacteria employ a set of intriguing mechanisms to prevent caspase-1 activation and secretion of IL-1β and IL-18 (Schotte et al., [@B59]). This Gram-negative pathogen makes use of a specialized type III secretion system to inject virulence factors called Yop proteins directly into the host cell cytosol. Among these effector proteins, YopE and YopT were shown to inhibit caspase-1 activation and the subsequent secretion of mature IL-1β (Schotte et al., [@B59]). These Yop proteins are known to target Rho GTPases, which are critical for cytoskeletal reorganization and phagocytosis. YopE accelerates GTP hydrolysis in order to keep Rho GTPase family members in the inactive GDP-bound state. By contrast, YopT is as a cysteine protease that inactivates Rho GTPases by removing the C-terminal prenyl membrane anchor that attaches them to the plasma membrane. Experiments with dominant-negative proteins and chemical inhibitors of the Rho GTPase Rac1 suggested a critical role for this Rho GTPase in inflammasome assembly and caspase-1 activation (Schotte et al., [@B59]). In addition to YopE and YopT, the *Yersinia pseudotuberculosis* effector protein YopK prevents recognition of the bacterial type III secretion system by the Nlrp3 and Nlrc4 inflammasomes in order to promote bacterial survival in host macrophages (Brodsky et al., [@B8]). Together, these findings suggest that *Yersinia* spp. may prevent caspase-1 activation by inflammasomes by interfering with Rho GTPases and by masking the type III secretion system. However, the precise molecular chain of events by which Yop effector proteins affect inflammasome activation requires further analysis. *L. pneumophila*, the causative agent of Legionnaire\'s disease, uses a different strategy to inhibit caspase-1 activation in human phagocytes. This pathogen downregulates transcription of the inflammasome adaptor ASC to interfere with caspase-1-mediated restriction of bacterial replication in human monocytes (Abdelaziz et al., [@B1]). *P. aeruginosa* isolates expressing the virulence factor exoenzyme U (ExoU) represent another example of Gram-negative pathogens interfering with inflammasome activation. Notably, *Pseudomonas* ExoU phospholipase A2 activity was shown to be required for inhibiting the Nlrc4 inflammasome-driven secretion of IL-1β and IL-18 from infected macrophages (Sutterwala et al., [@B66]). ExoS is another *Pseudomonas* effector protein demonstrated to interfere with inflammasome-induced IL-1β production. This virulence factor utilized its ADP-ribosyl transferase activity to inhibit caspase-1 activation (Galle et al., [@B17]). Also Gram-positive pathogens have evolved mechanisms to interfere with inflammasome function. For instance, *Mycobacterium tuberculosis* expresses a putative Zn^2+^ metalloprotease named Zmp1 that prevents inflammasome activation and IL-1β secretion (Master et al., [@B48]). Zmp1-mediated inhibition of caspase-1 activation was demonstrated to enhance bacterial survival in infected macrophages and to increase bacterial burdens in the lungs of aerosol-infected mice (Master et al., [@B48]).

Conclusions and Perspectives
============================

Caspase-1 activation by inflammasomes is a critical component of the host response to microbial pathogens. It induces secretion of HMGB1, IL-1β, and IL-18 and triggers pyroptosis of infected host cells in order to eliminate the infectious agent. It may thus be beneficial to microbial pathogens to prevent inflammasome assembly, to inhibit caspase-1 activation and activity and to interfere with downstream signaling cascades using decoy receptors. Studies showed that orthopoxviruses, influenza H1N1 virus and a variety of bacterial pathogens all evolved unique mechanisms to hijack the inflammasome machinery. Future studies will undoubtedly shed light on new and intriguing mechanisms by which bacterial and viral pathogens aim to silence the inflammasome.
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